BIT
ANIP icon

BlackRock Institutional Trust’s ANI Pharmaceuticals ANIP Stock Holding History

BlackRock Institutional Trust’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$13M Buy
214,908
+22,569
+12% +$1.38M ﹤0.01% 2245
2016
Q3 		$12.8M Buy
192,339
+3,163
+2% +$198K ﹤0.01% 2184
2016
Q2 		$10.6M Sell
189,176
-1,831
-1% -$89K ﹤0.01% 2259
2016
Q1 		$6.43M Sell
191,007
-376
-0.2% -$12.8K ﹤0.01% 2532
2015
Q4 		$8.64M Buy
191,383
+4,269
+2% +$184K ﹤0.01% 2424
2015
Q3 		$7.39M Sell
187,114
-60,845
-25% -$3.46M ﹤0.01% 2486
2015
Q2 		$15.4M Buy
247,959
+2,993
+1% +$178K ﹤0.01% 2102
2015
Q1 		$15.3M Buy
244,966
+994
+0.4% +$60.5K ﹤0.01% 2115
2014
Q4 		$13.8M Sell
243,972
-84,214
-26% -$3.71M ﹤0.01% 2162
2014
Q3 		$9.28M Buy
328,186
+43,850
+15% +$1.31M ﹤0.01% 2387
2014
Q2 		$9.79M Buy
284,336
+59,839
+27% +$1.88M ﹤0.01% 2450
2014
Q1 		$7.04M Sell
224,497
-8,570
-4% -$227K ﹤0.01% 2622
2013
Q4 		$4.68M Buy
233,067
+11,365
+5% +$147K ﹤0.01% 2815
2013
Q3 		$2.17M Buy
221,702
+13,497
+6% +$97.3K ﹤0.01% 3092
2013
Q2 		$1.25M Buy
+208,205
New +$1.46M ﹤0.01% 3267

Other funds holding ANIP

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BlackRock Institutional Trust's ANIP Position: Q4 2016 in Review

BlackRock Institutional Trust increased its ANI Pharmaceuticals (ANIP) stake by 12% in Q4 2016, buying an estimated $1.38M and bringing the position to 214,908 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

BlackRock Institutional Trust first reported a position in ANIP in Q2 2013 and has held it in 15 quarters since. The position peaked at $15.4M in Q2 2015. 157 funds tracked by Wall St. Rank hold ANIP as of Q4 2016.

  • BlackRock Institutional Trust held 214,908 shares of ANI Pharmaceuticals worth $13M as of Q4 2016.
  • BlackRock Institutional Trust bought 22,569 ANI Pharmaceuticals shares in Q4 2016, an estimated $1.38M.
  • ANI Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2245 holding.
  • BlackRock Institutional Trust first reported a position in ANI Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's ANI Pharmaceuticals position peaked at $15.4M in Q2 2015.
  • 157 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.